About
Verastem develops novel therapies targeting the RAS/MAPK pathway for the treatment of cancers, including KRAS-mutant recurrent low-grade serous ovarian cancer and other solid tumors.
Explore Verastem, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.